| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Recipient's age does not adversely affect pregnancy outcome after oocytedonation |
Legro, R.S.;Wong, I.L.;Paulson, R.J.;Lobo, R.A.;Sauer, M.V.; |
American Journal of Obstetrics and Gynecology |
1995-01-01 |
查看 |
| Triplet pregnancy in a 51-year-old woman after oocyte donation |
Sauer, M.V.;Paulson, R.J.;Lobo, R.A.; |
American Journal of Obstetrics and Gynecology |
1995-03-01 |
查看 |
| Introduction |
Lobo, R.A.; |
American Journal of Obstetrics and Gynecology |
1995-09-01 |
查看 |
| Benefits and risks of estrogen replacement therapy |
Lobo, R.A.; |
American Journal of Obstetrics and Gynecology |
1995-09-01 |
查看 |
| Alterations in androgen conjugate levels in women and men with alopecia |
Legro, R.S.;Carmina, E.;Stanczyk, F.Z.;Gentzschein, E.;Lobo, R.A.; |
International Journal of Gynecology & Obstetrics |
1995-06-01 |
查看 |
| The route of administration influences the effect of estrogen on insulinsensitivity in postmenopausal women |
Lindheim, S.R.;Duffy, D.M.;Kojima, T.;Vijod, M.A.;Stanczyk, F.Z.;Lobo, R.A.; |
International Journal of Gynecology & Obstetrics |
1995-08-01 |
查看 |
| Metabolic impact of adding medroxyprogesterone acetate to conjugatedestrogen therapy in postmenopausal women |
Lobo, R.A.;Pickar, J.H.;Wild, R.A.;Walsh, B.;Hirvonen, E.; |
International Journal of Gynecology & Obstetrics |
1995-08-01 |
查看 |
| Reassessment of Adrenal Androgen Secretion in Women With Polycystic OvarySyndrome |
Carmina, E.;Gonzalez, F.;Chang, L.;Lobo, R.A.; |
Obstetrics and Gynecology |
1995-06-01 |
查看 |
| Rare occurrence of ovarian hyperstimulation syndrome in oocyte donors |
Sauer, M.V.;Paulson, R.J.;Lobo, R.A.; |
International Journal of Gynecology & Obstetrics |
1996-03-01 |
查看 |
| Cardioprotective effects of individual conjugated equine estrogens throughtheir possible modulation of insulin resistance and oxidation oflow-density lipoprotein |
Wilcox, J.G.;Hwang, J.;Hodis, H.N.;Sevanian, A.;Stanczyk, F.Z.;Lobo, R.A.; |
International Journal of Gynecology & Obstetrics |
1997-04-01 |
查看 |
| Cardioprotective effects of individual conjugated equine estrogens throughtheir possible modulation of insulin resistance and oxidation oflow-density lipoprotein |
Wilcox, J.G.;Hwang, J.;Hodis, H.N.;Sevanian, A.;Stanczyk, F.Z.;Lobo, R.A.; |
International Journal of Gynecology & Obstetrics |
1997-04-01 |
查看 |
| Endothelin levels decrease after oral and non-oral estrogen inpost-menopausal women with increased cardiovascular risk factors |
Wilcox, J.G.;Stanczyk, F.Z.;Hatch, I.E.;Lobo, R.A.;Gentzschein, E.; |
International Journal of Gynecology & Obstetrics |
1997-05-01 |
查看 |
| Endothelin levels decrease after oral and non-oral estrogen inpost-menopausal women with increased cardiovascular risk factors |
Wilcox, J.G.;Stanczyk, F.Z.;Hatch, I.E.;Lobo, R.A.;Gentzschein, E.; |
International Journal of Gynecology & Obstetrics |
1997-05-01 |
查看 |
| A novel intermittent regimen of norgestimate to preserve the beneficialeffects of 17@b-estradiol on lipid and lipoprotein profiles |
Lobo, R.A.;Zacur, H.Z.;Caubel, P.;Lane, R.; |
American Journal of Obstetrics and Gynecology |
2000-01-01 |
查看 |
| Endometrial histologic effects of oral micronized progesterone inestrogen-treated postmenopausal women |
Archer, D.F.;Fuggie, C.A.;Lobo, R.A.;Speroff, L.;Rebar, R.W.;Moyer, D.L.; |
International Journal of Gynecology & Obstetrics |
2000-01-01 |
查看 |
| Endometrial histologic effects of oral micronized progesterone inestrogen-treated postmenopausal women |
Archer, D.F.;Fuggie, C.A.;Lobo, R.A.;Speroff, L.;Rebar, R.W.;Moyer, D.L.; |
International Journal of Gynecology & Obstetrics |
2000-01-01 |
查看 |
| Endometrial histologic effects of oral micronized progesterone inestrogen-treated postmenopausal women |
Archer, D.F.;Fuggie, C.A.;Lobo, R.A.;Speroff, L.;Rebar, R.W.;Moyer, D.L.; |
International Journal of Gynecology & Obstetrics |
2000-01-01 |
查看 |
| Perspectives on the Women's Health Initiative trial of hormone replacementtherapy |
Grimes, D.A.;Lobo, R.A.; |
Obstetrics and Gynecology |
2002-12-01 |
查看 |
| Perspectives on the Women's Health Initiative trial of hormone replacementtherapy Reply |
Grimes, D.A.;Lobo, R.A.; |
Obstetrics and Gynecology |
2003-04-01 |
查看 |
| Perspectives on the Women's Health Initiative trial of hormone replacementtherapyReply |
Grimes, D.A.;Lobo, R.A.; |
Obstetrics and Gynecology |
2003-04-01 |
查看 |
| Evaluation of cardiovascular- event rates with hormone replacement therapyin healthy postmenopausal women |
Lobo, R.A.;Pickar, J.H.; |
Obstetrics and Gynecology |
2003-04-01 |
查看 |
| Does ovarian blood flow distinguish between ovulatory and anovulatorypatients with polycystic ovary syndrome? |
Carmina, E.;Longo, A.;Lobo, R.A.; |
American Journal of Obstetrics and Gynecology |
2003-11-01 |
查看 |
| Does ovarian blood flow distinguish between ovulatory and anovulatorypatients with polycystic ovary syndrome? |
Carmina, E.;Longo, A.;Lobo, R.A.; |
American Journal of Obstetrics and Gynecology |
2003-11-01 |
查看 |
| Does metformin induce ovulation in normoandrogenic anovulatory women? |
Carmina, E.;Lobo, R.A.; |
American Journal of Obstetrics and Gynecology |
2004-11-01 |
查看 |
| Insulin resistance in postmenopausal women with metabolic syndrome andthe measurements of adiponectin, leptin, resistin, and ghrelin |
Chu, M.C.;Cosper, P.;Orio, F.;Carmina, E.;Lobo, R.A.; |
American Journal of Obstetrics and Gynecology |
2006-01-01 |
查看 |
| Insulin resistance in postmenopausal women with metabolic syndrome andthe measurements of adiponectin, leptin, resistin, and ghrelin |
Chu, M.C.;Cosper, P.;Orio, F.;Carmina, E.;Lobo, R.A.; |
American Journal of Obstetrics and Gynecology |
2006-01-01 |
查看 |
| Mullerian inhibiting substance and disrupted folliculogenesis inpolycystic ovary syndrome |
Wang, J.G.;Nakhuda, G.S.;Guarnaccia, M.M.;Sauer, M.V.;Lobo, R.A.; |
American Journal of Obstetrics and Gynecology |
2007-01-01 |
查看 |
| Mullerian inhibiting substance and disrupted folliculogenesis inpolycystic ovary syndrome |
Wang, J.G.;Nakhuda, G.S.;Guarnaccia, M.M.;Sauer, M.V.;Lobo, R.A.; |
American Journal of Obstetrics and Gynecology |
2007-01-01 |
查看 |
| Mullerian inhibiting substance and disrupted folliculogenesis inpolycystic ovary syndrome |
Wang, J.G.;Nakhuda, G.S.;Guarnaccia, M.M.;Sauer, M.V.;Lobo, R.A.; |
American Journal of Obstetrics and Gynecology |
2007-01-01 |
查看 |
|
|
